Skip to main content
. 2019 Nov 11;14(12):1773–1780. doi: 10.2215/CJN.03580319

Table 1.

Characteristics of United States veterans with incident urinary stone disease from 2007 to 2013

Characteristics Without 24-h Urine Testing (N=113,186; 87%) With 24-h Urine Testing (N=17,303; 13%)
Age (mean±SD, yr) 61±14 58±12
Sex (N, %)
 Male 107,383 (95%) 16,042 (93%)
 Female 5803 (5%) 1261 (7%)
Race (N, %)
 White 87,541 (77%) 13,803 (80%)
 Black 12,540 (11%) 1521 (9%)
 Other or unknown 13,105 (12%) 1979 (11%)
Laboratory data
 BMI (mean±SD, kg/m2) 29.9±6.2 30.7±6.3
 eGFR (mean±SD, ml/min per 1.73m2) 73±25 77±23
 Creatinine (mean±SD, mg/dl) 1.3±2.7 1.7±1.4
 Potassium (mean±SD, mEq/L) 4.2±0.5 4.2±1.1
 Sodium (mean±SD, mEq/L) 139±4 139±6
 Bicarbonate (mean±SD, mEq/L) 27±4 27±3
 Calcium (mean±SD, mg/dl) 9.3±1.4 10.2±1.6
 Albumin (mean±SD, g/dl) 4.1±15.1 4.1±1.2
Comorbidities (N, %)
 Hypertension 76,811 (68%) 10,944 (63%)
 Gout 6467 (6%) 1005 (6%)
 Osteoporosis 2530 (2%) 484 (3%)
 Osteopenia 2259 (2%) 441 (3%)
 Diabetes mellitus 42,214 (37%) 6690 (39%)
 CKD 3769 (3%) 430 (2%)
 Cardiovascular disease 9608 (8%) 947 (5%)
Baseline medications (N, %)
 Thiazide or thiazide-like diuretics 19,188 (17%) 2815 (16%)
 Alkali therapy 1000 (1%) 192 (1%)
 Allopurinol 5861 (5%) 890 (5%)
Geographic region (N, %)
 Midwest 27,962 (25%) 4795 (28%)
 Northeast 18,737 (17%) 2244 (13%)
 Southeast 43,521 (38%) 5314 (31%)
 West 22,966 (20%) 4950 (28%)

BMI, body mass index.